Is Dyne Therapeutics Inc (DYN) a Leader in the Biotechnology Industry?

Dyne Therapeutics Inc (DYN) is near the top in its industry group according to InvestorsObserver. DYN gets an overall rating of 75. That means it scores higher than 75 percent of stocks. Dyne Therapeutics Inc gets a 89 rank in the Biotechnology industry. Biotechnology is number 19 out of 148 industries.

DYN has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DYN!

See Full DYN Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 75 would rank higher than 75 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Dyne Therapeutics Inc Stock Today?

Dyne Therapeutics Inc (DYN) stock is lower by -2.46% while the S&P 500 has risen 0.05% as of 12:40 PM on Thursday, Mar 28. DYN has fallen -$0.70 from the previous closing price of $28.50 on volume of 307,260 shares. Over the past year the S&P 500 has risen 30.38% while DYN has risen 149.33%. DYN lost -$3.95 per share the over the last 12 months. Click Here to get the full Stock Report for Dyne Therapeutics Inc stock.